Encelo Laboratories company
Universal access to primary cells
Founded Date:
2017-12-01
Investor Type:
For Profit
Employee Number:
1-10
Funding Status:
Seed
Technology:
P4 Medicine
Last Funding Type:
Seed
Investors Number:
2
Industry:
Biotechnology, Science and Engineering
Headquarters:
London, England, United Kingdom
Estimated Revenue:
Less than $1M